Skip to main content
BBIO
NASDAQ Life Sciences

FDA Accepts BridgeBio's NDA for Encaleret, Sets May 2027 PDUFA Date

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$82.694
Mkt Cap
$16.163B
52W Low
$42.09
52W High
$93.415
52W Position info
96% above low
Off High info
11% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BBIO sits 96% above its 52-week low of $42.09 on light trading volume (0.4× avg).

Summary

The FDA accepted BridgeBio's NDA for encaleret in ADH1, assigning a PDUFA date of May 8, 2027. No advisory committee is planned, which may signal a straightforward review. Encaleret would be the first approved therapy for ADH1, targeting a diagnosed U.S. population of over 2,100 and growing. This follows the NDA submission in May 2026 and positive Phase 3 data. BridgeBio is also expanding the program into pediatric ADH1 and chronic hypoparathyroidism, broadening the potential market. The $1B financing in July provides ample runway to launch.

At the time of this announcement, BBIO was trading at $82.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.2B. The 52-week trading range was $42.09 to $93.42. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BBIO - Latest Insights

BBIO
Oct 29, 2026, 4:52 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $70.69
Real-time Price: $76.03 info
Change: +$5.34 (+8%) info
Market Cap: $14.811B info
BBIO
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.44
Real-time Price: $76.03 info
Change: +$4.59 (+6%) info
Market Cap: $14.811B info
BBIO
Oct 29, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $70.67
Real-time Price: $76.03 info
Change: +$5.36 (+8%) info
Market Cap: $14.811B info
BBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.75
Real-time Price: $76.03 info
Change: +$10.28 (+16%) info
Market Cap: $14.811B info
BBIO
Oct 11, 2026, 2:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $76.03 info
Change: +$10.68 (+16%) info
Market Cap: $14.811B info